AlphaFold predicted structure
AGL · P35573

Mean pLDDT
92.8/ 100
Very high
1,532 residues
Confidence breakdown
- Very high(≥ 90)80%
- Confident(70–90)18%
- Low(50–70)2%
- Very low(< 50)0%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Acute rhabdomyolysis
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalGlycogen storage disease
BIALLELIC, autosomal or pseudoautosomalKetotic hypoglycaemia
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalRhabdomyolysis and metabolic muscle disorders
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomal+7 more panels — install the extension to see the full list inline on any page.
glycogen storage disease III
disorder of glycogen metabolism
Glycogen storage disease due to glycogenin deficiency
hereditary disease
Acute rhabdomyolysis
Abnormality of metabolism/homeostasis
response to xenobiotic stimulus
exfoliative dermatitis
ileostomy
Meniere disease
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Glycogen debranching enzyme
Multifunctional enzyme acting as 1,4-alpha-D-glucan:1,4-alpha-D-glucan 4-alpha-D-glycosyltransferase and amylo-1,6-glucosidase in glycogen degradation
AGL · P35573

Mean pLDDT
92.8/ 100
Very high
1,532 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0